Notice to Local Authorities

Year: 2014

Notice circulated to Local Authorities regarding requirements of Industrial Emissions Directive and Regulations

Equilis RhodE Trial - Final Report

Year: 2014

Final report on the Equilis RhodE veterinary trial

Intervet Letter of 10 March 2014 re cessation of trial

Year: 2014

Correspondence received from Intervet International B.V. on 10 March 2014 to advise the Agency of their decision to stop the veterinary trial

International Credit Entitlement for Operators

Year: 2013

In accordance with Article 2.1 of Commission Regulation (EU) No. 1123/2013. International Credit Entitlement for Operators. Please be advised that this ICE Table is subject to approval by the European Commission and thus is subject to change.

EDEN Guidance for Managing WWD Authorisation Applications

Year: 2013

EDEN Guidance for Managing WWD Authorisation Applications Oct 2013

G0493-01 Inspector's Report to the Board of the Agency

Year: 2013

All documentation submitted in respect of this notification, including valid representations made by members of the public, was taken into consideration by the EPA Inspector in her report to the Board of the Agency.

Inspector's Memo to Board for approval to modify condition

Year: 2013

Inspector's Memo to Board for approval to modify condition

Letter from EPA to Intervet International BV with modified condition

Year: 2013

Letter from EPA to Intervet International BV, dated 11 June 2013, with modified condition

Board Minute Extract re decision on modified condition

Year: 2013

An extract from the Board Minute of the meeting of 10 June 2013,approving the modification of Condition 6.8

G0493-01 Valid representations received from members of the public

Representations received from members of the public in response to Intervet International BV's notification, June 2013

Year: 2013

The following valid representations were submitted in response to the notification by Intervet International BV, seeking consent to carry out a veterinary trial using a genetically modified vaccine

Non-confidential Annex List G0493

Year: 2013

List of non-confidential annexes received as part of Merck Sharp and Dohme/Intervet International BV's application G0493

Board minute extract for Agency Board Meeting of 9 April 2013

Year: 2013

An extract from the minutes of the EPA Board Meeting of 9 April 2013, at which Intervet International BV's notification seeking consent to carry out a veterinary trial at Belmont Stud, Co Offaly, was discussed.

GM equine vaccine Equilis RhodE application

Year: 2013

Non-confidential application documentation for Merck Sharp and Dohme application on behalf of Intervet International BV for consent to carry out a clinical study with a GM vaccine

Requests for further information, and responses received

Year: 2013

Requests from the Agency to the notifier for additional information, and the responses received, including an amended SNIF.

How to make a representation for G0493-01

Year: 2013

How to make a representation to the EPA about the proposed Deliberate Release G0493

G0493-01 Consent Conditions

Year: 2013

G0493-01 Consent Conditions issued to Intervet International BV on 10 April 2013 for veterinary trial using a genetically modified vaccine

A Resource Opportunity

Waste Management Policy in Ireland, April 2013

Year: 2013

This policy document sets out the measure through which Ireland will make the further pogress necessary to become a recycling society, with a clear focus on resource efficiency and the virtual elimination of landfilling of municipal waste. This is a Department of Environment, Community and Local Government publication.

Dumping at Sea Enforcement and Permitting Booklet

Year: 2013

Guidance document for applying for a Dumping at Sea permit

G0498-01 Inspector's Report

Year: 2013

All documentation submitted in respect of this notification was taken into consideration by the EPA Inspector in her report to the Board of the Agency

Board Minute Extract of 25 June 2013

Year: 2013

An extract from the minutes of the EPA Board Meeting of 25 June 2013 at which the Centre for Cellular and Molecular Therapeutics' notification seeking consent to carry out a clinical trial at St James's Hospital Dublin was discussed

Pagination